O4‐04‐04: Pooled biomarker analyses of phase 2 studies of vanutide cridificar vaccine (ACC‐001) in mild‐to‐moderate and early Alzheimer's disease
Year: 2015
Type: article
Source: Alzheimer s & Dementia
Institutions: Pfizer (United States), Pfizer (France), Columbia University
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2408825584
